+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | BG505 SOSIP in complex with 007 bNAb IgG1 - trimer-dimer class | |||||||||
Map data | Sharpened EM map | |||||||||
Sample |
| |||||||||
Keywords | antibody / envelope / SOSIP / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||
| Function / homology | Function and homology informationpositive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane ...positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / identical protein binding / membrane Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) / ![]() Human immunodeficiency virus 1 | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 4.2 Å | |||||||||
Authors | DeLaitsch AT / Bjorkman PJ | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: bioRxiv / Year: 2025Title: Identification of a broad and potent V3 glycan site bNAb targeting an N332 glycan-independent epitope. Authors: Lutz Gieselmann / Andrew T DeLaitsch / Malena Rohde / Caelan Radford / Johanna Worczinski / Anna Momot / Elvin Ahmadov / Judith A Burger / Colin Havenar-Daughton / Sharvari Deshpande / ...Authors: Lutz Gieselmann / Andrew T DeLaitsch / Malena Rohde / Caelan Radford / Johanna Worczinski / Anna Momot / Elvin Ahmadov / Judith A Burger / Colin Havenar-Daughton / Sharvari Deshpande / Federico Giovannoni / Davide Corti / Christoph Kreer / Meryem Seda Ercanoglu / Philipp Schommers / Ivelin S Georgiev / Anthony P West / Jacqueline Knüfer / Ricarda Stumpf / Arne Kroidl / Christof Geldmacher / Lucas Maganga / Wiston William / Nyanda E Ntinginya / Michael Hoelscher / Zhengrong Yang / Qing Wei / Matthew Renfrow / Todd J Green / Jan Novak / Marit J van Gils / Harry B Gristick / Henning Gruell / Jesse D Bloom / Michael S Seaman / Pamela J Bjorkman / Florian Klein / ![]() Abstract: Broadly neutralizing antibodies (bNAbs) against HIV-1 can suppress viremia and inform vaccine development. Here, we characterized 007, a V3 glycan site bNAb exhibiting high levels of antiviral ...Broadly neutralizing antibodies (bNAbs) against HIV-1 can suppress viremia and inform vaccine development. Here, we characterized 007, a V3 glycan site bNAb exhibiting high levels of antiviral activity against multiclade pseudovirus panels (GeoMean IC = 0.012 μg/mL, breadth = 69%, 217 virus strains) by targeting a N332 glycan-independent V3 epitope, a site of Env vulnerability to which only weakly neutralizing antibodies had previously been identified. Functional analyses demonstrated distinct binding and neutralization profiles compared to classical V3 glycan site bNAbs. A 007 Fab-Env cryo-EM structure revealed contacts with the V3 GD/NIR motif and interactions with N156 and N301 glycans. In contrast to classical V3 bNAbs, 007 binding to Env does not depend on the N332 glycan, rendering it resistant to common escape mutations. Structures of 007 IgG-Env trimer complexes showed two Env trimers crosslinked by three bivalent IgGs, and bivalent 007 IgG was up to ~300-fold more potent than monovalent 007 IgG heterodimer, suggesting a role for avidity in potent neutralization. Finally, in HIV-1-infected humanized mice, 007 caused transient decline of viremia and overcame classical V3 escape mutations, highlighting 007's potential for HIV-1 prevention, therapy, functional cure, and vaccine design. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_70022.map.gz | 168.2 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-70022-v30.xml emd-70022.xml | 26 KB 26 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_70022_fsc.xml | 11.9 KB | Display | FSC data file |
| Images | emd_70022.png | 88.9 KB | ||
| Filedesc metadata | emd-70022.cif.gz | 7.7 KB | ||
| Others | emd_70022_additional_1.map.gz emd_70022_half_map_1.map.gz emd_70022_half_map_2.map.gz | 89.5 MB 164.6 MB 164.6 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-70022 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-70022 | HTTPS FTP |
-Validation report
| Summary document | emd_70022_validation.pdf.gz | 908.5 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_70022_full_validation.pdf.gz | 908.1 KB | Display | |
| Data in XML | emd_70022_validation.xml.gz | 20.5 KB | Display | |
| Data in CIF | emd_70022_validation.cif.gz | 26.9 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-70022 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-70022 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9o2uMC ![]() 9o2qC ![]() 9o2rC ![]() 9o2sC ![]() 9o2tC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_70022.map.gz / Format: CCP4 / Size: 178 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Sharpened EM map | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.44 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Additional map: Unsharpened EM map
| File | emd_70022_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Unsharpened EM map | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: EM half map A
| File | emd_70022_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | EM half map A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: EM half map B
| File | emd_70022_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | EM half map B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : HIV-1 BG505 SOSIP trimer bound by three 007 bNAb IgG1 molecules
| Entire | Name: HIV-1 BG505 SOSIP trimer bound by three 007 bNAb IgG1 molecules |
|---|---|
| Components |
|
-Supramolecule #1: HIV-1 BG505 SOSIP trimer bound by three 007 bNAb IgG1 molecules
| Supramolecule | Name: HIV-1 BG505 SOSIP trimer bound by three 007 bNAb IgG1 molecules type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#4 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Envelope glycoprotein gp120
| Macromolecule | Name: Envelope glycoprotein gp120 / type: protein_or_peptide / ID: 1 / Number of copies: 6 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
| Molecular weight | Theoretical: 53.3925 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: NLWVTVYYGV PVWKDAETTL FCASDAKAYE TEKHNVWATH ACVPTDPNPQ EIHLENVTEE FNMWKNNMVE QMHTDIISLW DQSLKPCVK LTPLCVTLQC TNVTNNITDD MRGELKNCSF NMTTELRDKK QKVYSLFYRL DVVQINENQG NRSNNSNKEY R LINCNTSA ...String: NLWVTVYYGV PVWKDAETTL FCASDAKAYE TEKHNVWATH ACVPTDPNPQ EIHLENVTEE FNMWKNNMVE QMHTDIISLW DQSLKPCVK LTPLCVTLQC TNVTNNITDD MRGELKNCSF NMTTELRDKK QKVYSLFYRL DVVQINENQG NRSNNSNKEY R LINCNTSA ITQACPKVSF EPIPIHYCAP AGFAILKCKD KKFNGTGPCP SVSTVQCTHG IKPVVSTQLL LNGSLAEEEV MI RSENITN NAKNILVQFN TPVQINCTRP NNNTRKSIRI GPGQAFYATG DIIGDIRQAH CNVSKATWNE TLGKVVKQLR KHF GNNTII RFANSSGGDL EVTTHSFNCG GEFFYCNTSG LFNSTWISNT SVQGSNSTGS NDSITLPCRI KQIINMWQRI GQAM YAPPI QGVIRCVSNI TGLILTRDGG STNSTTETFR PGGGDMRDNW RSELYKYKVV KIEPLGVAPT RCKRRVVGRR R UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #2: Envelope glycoprotein gp41
| Macromolecule | Name: Envelope glycoprotein gp41 / type: protein_or_peptide / ID: 2 / Number of copies: 6 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
| Molecular weight | Theoretical: 17.618064 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: RRRAVGIGAV FLGFLGAAGS TMGAASMTLT VQARNLLSGI VQQQSNLLRA PEAQQHLLKL TVWGIKQLQA RVLAVERYLR DQQLLGIWG CSGKLICCTN VPWNSSWSNR NLSEIWDNMT WLQWDKEISN YTQIIYGLLE ESQNQQEKNE QDLLALD UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #3: 007 IgG1 Heavy Chain
| Macromolecule | Name: 007 IgG1 Heavy Chain / type: protein_or_peptide / ID: 3 / Number of copies: 6 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 50.497047 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QARLQQWEGR PLKPAETLSL TCGVHGVGLG GSGWGWIRQP PGQGLQWIGE IDHDGSHKHN PALRSRLSMS LDTSRNQVSL RLTSVTAAD TAIYYCVRVY REKFLIGEFL TDYRFMDMWG TGTTVIVSPA STKGPSVFPL APSSKSTSGG TAALGCLVKD Y FPEPVTVS ...String: QARLQQWEGR PLKPAETLSL TCGVHGVGLG GSGWGWIRQP PGQGLQWIGE IDHDGSHKHN PALRSRLSMS LDTSRNQVSL RLTSVTAAD TAIYYCVRVY REKFLIGEFL TDYRFMDMWG TGTTVIVSPA STKGPSVFPL APSSKSTSGG TAALGCLVKD Y FPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PC PAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVL HQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPEN NYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK |
-Macromolecule #4: 007 Light Chain
| Macromolecule | Name: 007 Light Chain / type: protein_or_peptide / ID: 4 / Number of copies: 6 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.50027 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: AIQLTQAPLT VSASIGDTIT LTCRASQDIS IWLSWYRQMP GKAPELLIYA ASTLRGGVPS RFSGARSGTD FSLKIKNLQP EDFATYYCF QSDSYPRAFG QGTKVEITRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS ...String: AIQLTQAPLT VSASIGDTIT LTCRASQDIS IWLSWYRQMP GKAPELLIYA ASTLRGGVPS RFSGARSGTD FSLKIKNLQP EDFATYYCF QSDSYPRAFG QGTKVEITRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC |
-Macromolecule #8: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 8 / Number of copies: 48 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 2.6 mg/mL | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 8 Component:
| |||||||||
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Pretreatment - Type: GLOW DISCHARGE | |||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 295 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | FEI TALOS ARCTICA |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Number grids imaged: 1 / Number real images: 2290 / Average electron dose: 45.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 3.0 µm / Nominal defocus min: 1.0 µm |
| Experimental equipment | ![]() Model: Talos Arctica / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Initial model |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Details | chains individually rigid body fit into density | ||||||||||
| Refinement | Protocol: RIGID BODY FIT | ||||||||||
| Output model | ![]() PDB-9o2u: |
Movie
Controller
About Yorodumi




Keywords
Homo sapiens (human)
Human immunodeficiency virus 1
Authors
United States, 1 items
Citation













Z (Sec.)
Y (Row.)
X (Col.)













































FIELD EMISSION GUN





